Terms: = Lymphoma AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
36 results:
1. Artemisinin Confers Cytoprotection toward Hydrogen Peroxide-Induced Cell Apoptosis in Retinal Pigment Epithelial Cells in Correlation with the Increased Acetylation of Histone H4 at Lysine 8.
Yang C; Ge L; Yu X; Lazarovici P; Zheng W
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675608
[TBL] [Abstract] [Full Text] [Related]
2. [In vitro pharmacodynamic studies of novel class Ⅰ and Ⅱb selective histone deacetylase inhibitor purinostat mesylate in the treatment of diffuse large B-cell lymphoma and its mechanism].
Wang J; Zhao AL; Li H; Yang LY; Chen LJ; Niu T
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):753-759. PubMed ID: 36709169
[No Abstract] [Full Text] [Related]
3. Histamine H4 Receptor Agonism Induces Antitumor Effects in Human T-Cell lymphoma.
Clauzure M; Táquez Delgado MA; Phillip JM; Revuelta MV; Cerchietti L; Medina VA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163302
[TBL] [Abstract] [Full Text] [Related]
4. Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
Yoshida K; Fujita A; Narazaki H; Asano T; Itoh Y
Cancer Chemother Pharmacol; 2022 Jan; 89(1):83-91. PubMed ID: 34825941
[TBL] [Abstract] [Full Text] [Related]
5. Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma.
Sloan SL; Renaldo KA; Long M; Chung JH; Courtney LE; Shilo K; Youssef Y; Schlotter S; Brown F; Klamer BG; Zhang X; Yilmaz AS; Ozer HG; Valli VE; Vaddi K; Scherle P; Alinari L; Kisseberth WC; Baiocchi RA
PLoS One; 2021; 16(5):e0250839. PubMed ID: 33989303
[TBL] [Abstract] [Full Text] [Related]
6. Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance.
Yang Q; Zhang R; Tang P; Sun Y; Johnson C; Saredy J; Wu S; Wang J; Lu Y; Saaoud F; Shao Y; Drummer C; Xu K; Yu D; Li R; Ge S; Jiang X; Wang H; Yang X
J Immunol Res; 2021; 2021():6664453. PubMed ID: 33628851
[TBL] [Abstract] [Full Text] [Related]
7. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.
Zhang GQ; Jiao Q; Shen CT; Song HJ; Zhang HZ; Qiu ZL; Luo QY
Cancer Sci; 2021 Mar; 112(3):997-1010. PubMed ID: 33247999
[TBL] [Abstract] [Full Text] [Related]
8. Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities.
Zhao N; Yang F; Han L; Qu Y; Ge D; Zhang H
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046013
[TBL] [Abstract] [Full Text] [Related]
9. Repositioning of Difluorinated Propanediones as Inhibitors of Histone Methyltransferases and their Biological Evaluation in Human Leukemic Cell Lines.
Pal T; Sharda A; Khade B; Ramaa CS; Gupta S
Anticancer Agents Med Chem; 2018; 18(13):1892-1899. PubMed ID: 29623853
[TBL] [Abstract] [Full Text] [Related]
10. Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
Cho H; Yoon DH; Kim KP; Bae KS; Kim WS; Eom HS; Kim JS; Hong JY; Kim SJ; Lee H; Kim SJ; Suh C
Invest New Drugs; 2018 Oct; 36(5):877-885. PubMed ID: 29520651
[TBL] [Abstract] [Full Text] [Related]
11. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
Borutinskaitė V; Virkšaitė A; Gudelytė G; Navakauskienė R
Leuk Lymphoma; 2018 Feb; 59(2):469-478. PubMed ID: 28641467
[TBL] [Abstract] [Full Text] [Related]
12. Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.
Che F; Heng X; Zhang H; Su Q; Zhang B; Chen Y; Zhang Z; Du Y; Wang L
Cancer Immunol Immunother; 2017 Jun; 66(6):717-729. PubMed ID: 28246881
[TBL] [Abstract] [Full Text] [Related]
13. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract] [Full Text] [Related]
14. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract] [Full Text] [Related]
15. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract] [Full Text] [Related]
16. Histone deacetylase HDAC1 downregulates transcription of the serotonin transporter (5-HTT) gene in tumor cells.
Phi van DK; Mühlbauer E; Phi-van L
Biochim Biophys Acta; 2015 Aug; 1849(8):909-18. PubMed ID: 26024595
[TBL] [Abstract] [Full Text] [Related]
17. PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo.
Rahmani M; Aust MM; Benson EC; Wallace L; Friedberg J; Grant S
Clin Cancer Res; 2014 Sep; 20(18):4849-60. PubMed ID: 25070836
[TBL] [Abstract] [Full Text] [Related]
18. BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.
Locatelli SL; Cleris L; Stirparo GG; Tartari S; Saba E; Pierdominici M; Malorni W; Carbone A; Anichini A; Carlo-Stella C
Leukemia; 2014 Sep; 28(9):1861-71. PubMed ID: 24561519
[TBL] [Abstract] [Full Text] [Related]
19. Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
Nam NH; Huong TL; Dung do TM; Dung PT; Oanh DT; Quyen D; Thao le T; Park SH; Kim KR; Han BW; Yun J; Kang JS; Kim Y; Han SB
Eur J Med Chem; 2013; 70():477-86. PubMed ID: 24185378
[TBL] [Abstract] [Full Text] [Related]
20. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.
Picaud S; Da Costa D; Thanasopoulou A; Filippakopoulos P; Fish PV; Philpott M; Fedorov O; Brennan P; Bunnage ME; Owen DR; Bradner JE; Taniere P; O'Sullivan B; Müller S; Schwaller J; Stankovic T; Knapp S
Cancer Res; 2013 Jun; 73(11):3336-46. PubMed ID: 23576556
[TBL] [Abstract] [Full Text] [Related]
[Next]